ArticleParasites & vectors2026
Hair quantitative PCR outperforms blood analysis for detecting Leishmania DNA in dogs: a non-invasive tool for clinical states of infection.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCanine leishmaniosis, caused by Leishmania infantum, is a significant zoonotic disease threatening both canine and human health worldwide. Early and accurate diagnosis is crucial for effective treatment and control. The use of hair samples for molecular diagnosis of L. infantum infection in dogs is a relatively novel approach and has not yet been extensively studied. Despite recent advances in blood-based polymerase chain reaction (PCR), noninvasive alternatives like hair quantitative PCR (qPCR) remain underexplored for different clinical states of infection. This study evaluates the utility of hair samples for qPCR diagnosis compared with traditional blood-based methods in different clinical states of infection.
methodsA total of 134 dogs from various regions of Spain, classified into healthy seronegative (n = 14), healthy seropositive (n = 59), or clinically sick (n = 61) were studied. Most sick dogs were in LeishVet stage IIa. Hair ear (n = 97) or neck (n = 37) and blood samples (n = 134) were collected. Diagnostic methods included quantitative in-house enzyme-linked immunosorbent assay (ELISA), endpoint ELISA, interferon gamma (IFN-γ) release whole blood assay, and hair and blood qPCR for Leishmania spp.
resultsHair qPCR showed significantly (P < 0.001) higher sensitivity in sick dogs (74%) compared with blood qPCR (36%) while no differences were found in healthy seropositive dogs (P = 0.593). IFN-γ production was not associated with hair qPCR positivity in either healthy seropositive or sick dogs. However, medium/high ELISA seropositivity was associated with substantially increased qPCR positivity in both blood (P = 0.002) and hair (P < 0.001). Sick dogs exhibited significantly higher antibody levels (P < 0.001), while healthy seropositive dogs showed stronger IFN-γ responses (P = 0.027).
conclusionsHair qPCR is a sensitive, non-invasive diagnostic tool for detecting Leishmania DNA in sick dogs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.